NIPRD Partners Bloom to Strengthen Pharmaceutical Research in Nigeria

The global public health response to the Covid-19 pandemic has led to emergency efforts to find medicines to prevent or treat the infection, which contributes to the impairing effect on the essential medicines supply chains as a result of some medicines’ candidacy for the covid-19 treatment. In this light, the National Institute of Pharmaceutical Research and Development (NIPRD) is partnering with Bloom Public Health (Bloom) through a Memorandum of Understanding (MoU) to facilitate the strengthening of its capacity on research and development of pharmaceuticals to ensure the availability of quality medicines to all Citizens of Nigeria during and post the covid-19 pandemic.

Per the MOU, Bloom will facilitate other collaborations within Africa to support NIPRD in playing a leadership role in the pharmaceutical quality space. Additionally, Bloom will serve as NIPRD’s technical partner for accessing and implementing donor funded initiatives to enhance NIPRD’s impact in Nigeria.

The CEO, Bloom Public Health, Professor Chimezie Anyakora said, “The covid19 pandemic amplifies the urgent need to strengthen the Nigerian Pharmaceutical sector and NIPRD as an institution is extremely instrumental to the growth and development of the sector. This partnership will ensure that NIPRD is fully supported technically to lead our country’s pharmaceutical sector reform and we are honored and privileged to be able to contribute our quota to this great journey. The Bloom Public Health and NIPRD partnership will catalyze a pharmaceutical renaissance and we are looking forward to the impact it will have on public health.”

Commenting on this, the Director General, NIPRD, Dr. Obi Peter Adigwe stated that “the partnership between Bloom and NIPRD is the type of Africa-led collaboration that will revolutionize the development of home-grown solutions for our healthcare issues. With NIPRD being one of a kind in the Region and also statutorily charged with the responsibility for research and development of drugs, vaccines, phytomedicines and commodities, our strategic plan is to use carefully nurtured partnerships with institutions, Nigerian and Foreign universities and funding agencies to stimulate local production of excipients, pharma inputs, quality medicines and other innovative interventions for the sector. We are glad to partner with Bloom Public Health as it is just the sort of contextual alliance that can expedite access to healthcare for our people”.

Given the shared interest, both Parties desire to work together on a mutual strategy of strengthening the health systems to guarantee access to safe and affordable health products for Nigerians.

You can also read about the Association of Industrial Pharmacists of Nigeria (NAIP) signing an MoU With Bloom Public Health to Boost Pharmaceutical Manufacturing. Click here https://bit.ly/2XZfObP